“NEUROPROTECTIVE EFFECTS OF SEMAGLUTIDE AND TIRZEPATIDE DURING THE TREATMENT OF OBESITY AND TYPE 2 DIABETES MELLITUS”, EIC, pp. 137–145, Nov. 2025, Accessed: Jan. 24, 2026. [Online]. Available: https://periodicos.newsciencepubl.com/editoraimpacto/article/view/10224